ONPATTRO 2mg/ml concentrate for solution for infusion ALNYLAM NETHERLANDS ORIGINAL MEDICINE
Chemical substance: patisiran
ATC code: N07XX12 • Nervous system | Other nervous system drugs | Other nervous system drugs
Active substance
Results for the substance patisiran
1 result
About this active substance
Patisiran is a medication used for the treatment of hereditary transthyretin-mediated amyloidosis (hATTR), a rare condition that affects the nerves and other organs. It is a small interfering RNA (siRNA) that reduces transthyretin production, slowing disease progression.
The medication is administered via intravenous infusion, as directed by your doctor. It is important to follow the administration schedule and monitor for any adverse reactions.
Side effects may include infusion site reactions, fatigue, nausea, or headache. In rare cases, severe allergic reactions or liver function impairment may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of patisiran.
The medication is administered via intravenous infusion, as directed by your doctor. It is important to follow the administration schedule and monitor for any adverse reactions.
Side effects may include infusion site reactions, fatigue, nausea, or headache. In rare cases, severe allergic reactions or liver function impairment may occur.
Patients should inform their doctor about any other medications being used or pre-existing conditions to ensure the safe use of patisiran.